These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14514609)

  • 21. [New-onset type 1 diabetes: what to do, differential diagnosis and prevention].
    Achenbach P; Hummel M
    MMW Fortschr Med; 2011 May; 153(20):45-7. PubMed ID: 21644293
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoimmune (type 1) diabetes in young adults in Sweden.
    Ostman J; Lernmark A; Landin-Olsson M; Sundkvist G; Palmer J; Arnqvist H; Blohmé G; Lithner F; Littorin B; Nyström L; Scherstén B; Wibell L
    Horm Metab Res; 1996 Jul; 28(7):348-50. PubMed ID: 8858383
    [No Abstract]   [Full Text] [Related]  

  • 23. First-degree relatives of persons with type 1 diabetes: insulin resistance and enterovirus infection are associated with different patterns of islet cell autoimmunity.
    Cubas-Dueñas I; Cabrera-Rode E; Sarmiento L; Molina G; Fonseca M; Arranz C; Domínguez E; González P; Vera M; Díaz-Horta O
    Acta Diabetol; 2013 Apr; 50(2):233-9. PubMed ID: 21604002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Humoral autoimmunity in diabetic patients].
    Pouplard A; Bottazzo GF; Doniach D
    Nouv Presse Med; 1977 Jan; 6(4):269-72. PubMed ID: 189288
    [No Abstract]   [Full Text] [Related]  

  • 25. beta Cell autoimmunity in a child with M.O.D.Y. (Maturity Onset Diabetes in the Young).
    Ortega-Rodriguez E; Levy-Marchal C; Guillermine S; Polak M
    Diabetes Metab; 2001 Feb; 27(1):59-61. PubMed ID: 11240447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Islet cell antibodies and diabetes mellitus.
    Jackson WP
    S Afr Med J; 1977 May; 51(21):733-4. PubMed ID: 327582
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical significance of islet cell antibody and islet cell surface antibody in diabetics].
    Iwo K
    Nihon Rinsho; 1990 Dec; 48 Suppl():300-7. PubMed ID: 2086903
    [No Abstract]   [Full Text] [Related]  

  • 28. Islet cell antibodies in diabetes mellitus.
    Qureshi SA; Tayyab M
    J Pak Med Assoc; 1991 Mar; 41(3):67-8. PubMed ID: 2033785
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diabetes caused by insulin-receptor antibodies. Autoimmune diabetes caused by anti-islands of Langerhans immunity].
    Boitard C; Timsit J; Assan R; Bach JF
    Rev Prat; 1986 Dec; 36(59-60):3500-4. PubMed ID: 3544174
    [No Abstract]   [Full Text] [Related]  

  • 30. Organ-specific cell-mediated autoimmunity in diabetes mellitus.
    Irvine WJ; Mac Cuish AC; Campbell CJ; Duncan LJ
    Acta Endocrinol Suppl (Copenh); 1976; 205():65-76. PubMed ID: 793280
    [No Abstract]   [Full Text] [Related]  

  • 31. The fallacy of reduction.
    Rewers M
    Pediatr Diabetes; 2012 Jun; 13(4):340-3. PubMed ID: 22059463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The immunological aspects of the development of diabetes mellitus and its complications].
    Kamaeva OI
    Ter Arkh; 1994; 66(10):14-7. PubMed ID: 7863435
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-cell autoimmunity, genetic susceptibility, and progression to type 1 diabetes in unaffected schoolchildren.
    Kulmala P; Rahko J; Savola K; Vähäsalo P; Sjöroos M; Reunanen A; Ilonen J; Knip M
    Diabetes Care; 2001 Jan; 24(1):171-3. PubMed ID: 11194225
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus.
    Del Prete GF; Betterle C; Padovan D; Erle G; Toffolo A; Bersahi G
    Diabetes; 1977 Oct; 26(10):909-15. PubMed ID: 332567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prediction of insulin-dependent diabetes in the general population].
    Czernichow P; Levy-Marchal C; Tichet J; Dubois F
    Journ Annu Diabetol Hotel Dieu; 1997; ():217-28. PubMed ID: 9296977
    [No Abstract]   [Full Text] [Related]  

  • 36. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.
    Taniguchi T; Okazaki K; Okamoto M; Seko S; Uchida K; Seino Y
    Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure.
    Soeldner JS; Tuttleman M; Srikanta S; Ganda OP; Eisenbarth GS
    N Engl J Med; 1985 Oct; 313(14):893-4. PubMed ID: 3897867
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunoenzyme detection of autoantibodies to the surface of pancreatic islet cells in diabetes mellitus and in increased risk of its development].
    Kondrat'ev IuIu; Sadovnikova NV; Kuraeva TL; Shcherbacheva LN; Smirnova OM
    Probl Endokrinol (Mosk); 1987; 33(2):3-6. PubMed ID: 3299355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes.
    Redondo MJ; Evans-Molina C; Steck AK; Atkinson MA; Sosenko J
    Diabetes Care; 2019 Aug; 42(8):1357-1364. PubMed ID: 31167894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.